Restless legs - A much neglected syndrome;Restless legs: Föa uppmärksammat syndrom

Lakartidningen

Volumn 96, Issue 10, 1999, Pages 1183-1188

  Ulfberg, Jan ^a,d   Jönsson, Roine ^a   Lindberg, Eva ^b   Nyström, Birgitta ^a   Mallon, Lena ^c  

^a Överläkare ^*  (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c FALUN HOSPITAL   (Sweden)

^d Lasarettet   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CLONAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADOLESCENT; ADULT; GENETICS; HUMAN; NOMENCLATURE; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; RESTLESS LEGS SYNDROME; REVIEW; SLEEP DISORDER;

ADOLESCENT; ADULT; ANTICONVULSANTS; CLONAZEPAM; DOPAMINE AGENTS; HUMANS; LEVODOPA; POLYSOMNOGRAPHY; RESTLESS LEGS SYNDROME; SLEEP DISORDERS; TERMINOLOGY;

EID: 0033540870     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Wetter TC, Pollmächer T. Restless legs and periodic leg movements in sleep syndromes. J Neurol 1997; 244 suppl 1: 37-45.
2. Walters AS, Hickey K, Maltzman J, Verrico T, Joseph D, Hening W et al. A questionnaire study of 138 patients with restless legs syndrome: The »Night-Walkers» survey. Neurology 1996; 46: 92-5.
3. Montplaisir J, Godbout R, Pelletier G, Warnes H. Restless legs syndrome and periodic movements during sleep. In: Kryger MH, Roth T, Dement WC, eds. Principles and practice of sleep medicine. Philadelphia: Saunders, 1994: 589-67.
4. Ekbom KA. Restless legs. Acta Med Scand 1945; 158 suppl: 1-123.
5. Symonds CP. Nocturnal myoclonus. J Neurol Neurosurg Psychiatry 1953; 16: 166-71.
6. Coleman R, Pollack C, Weitzman E. Periodic movements in sleep (nocturnal myoclonus): Relation to sleep disorders. Ann Neurol 1980; 8: 416-21.
7. Gibb WRG, Lees AJ. The restless legs syndrome. Postgrad Med J 1986; 62: 329-33.
8. Lavigne GJ, Montplaisir J. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 1994; 17: 739-43.
9. Walters AS and The international restless legs syndrome study group. Toward a better definition of the restless legs syndrome. Mov Disord 1995; 10: 634-42.
10. Walters AS, Picchietti D, Hening W, Lazzarini A. Variable expressivity in familial restless legs syndrome. Arch Neurol 1990; 47: 1219-20.
11. Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lespérance P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: A study of 133 patients diagnosed with new standard criteria. Mov Disord 1997; 12: 61-5.
12. Ondo W, Jankovic J. Restless legs syndrome: Clinicoetiologic correlates. Neurology 1996; 47: 1435-41.
13. Read DJ, Feest TG, Nassim MA. Clonapam: effective treatment for restless legs syndrome in uremia. BMJ 1981; 283: 885-6.
14. O'Keeffe ST, Gavin K, Lavan N. Iron status and restless legs syndrome in the elderly. Age Ageing 1994; 23: 200-23.
15. Goodman JDS, Brodie C, Ayida GA. Restless legs syndrome in pregnancy. BMJ 1988; 297: 1101-12.
16. Ulfberg J, Carter N, Talbäck M, Edling C. Excessive daytime sleepiness at work and subjective work performance in the general population and among heavy snorers and obstructive sleep apnea patients. Chest 1996; 110: 659-63.
17. Walters AS, Picchietti DL, Ehrenberg BL, Wagner ML. Restless legs syndrome in childhood and adolescence. Pediatr Neurol 1994; 11: 241-5.
18. von Scheele C. Levodopa in restless legs. Lancet 1986; 2: 426-7.
19. Von Scheele C, Kempi V. Long-term effect of dopaminergic drugs in restless legs. A 2-year follow up. Arch Neurol 1990; 47: 1223-4.
20. Peled R, Lavie P. Double-blind evaluation of clonazepam on periodic leg movements in sleep. J Neurol Neurosurg Psychiatry 1987; 50: 1679-81.